Skip to main content
ORPEA logo

ORPEA — Investor Relations & Filings

Ticker · ORP ISIN · FR001400NLM4 LEI · 969500LHIH3NT7PK1V89 PA Human health and social work activities
Filings indexed 760 across all filing types
Latest filing 2022-01-24 Legal Proceedings Report
Country FR France
Listing PA ORP

emeis, formerly known as Orpea SA, is a multinational corporation specializing in dependency care. The company operates a diverse network of facilities, including nursing homes, retirement homes, and assisted living residences. Its core services encompass long-term care for the elderly, post-acute and rehabilitation care, and mental health services through specialized psychiatric clinics. The group provides comprehensive support for individuals with varying levels of dependency, offering both residential and homecare solutions. The rebranding to emeis in 2024 marked a new phase for the company, aiming to move past previous operational challenges.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Legal Proceedings Report Classification · 1% confidence The document is a press release dated January 24, 2022, issued by ORPEA in response to damaging allegations published in a newspaper article regarding the company's operations. The text formally rejects the accusations, mentions potential legal action, and provides general company information and investor relations contacts. This is not a standard regulatory filing like a 10-K, an earnings release (ER), or a formal legal update (LTR). It is a direct communication addressing a specific, potentially damaging event or controversy. Since it is a formal statement reacting to external events and is not covered by more specific categories (like DIRS, DIV, or CAP), it best fits the general 'Regulatory Filings' category as a miscellaneous regulatory announcement or a response to a developing situation that requires public disclosure, which aligns with the definition of RNS (Regulatory Filings) as a fallback for non-specific announcements.
2022-01-24 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly information relating to the total number of voting rights and shares comprising the share capital) and references French commercial code articles (L.233-8-II) and AMF regulations. It provides a declaration as of December 31, 2021, detailing the number of shares, gross voting rights, and exercisable voting rights. This content directly relates to the structure of voting rights and share capital, which aligns best with the definition of a filing concerning share capital changes or regulatory disclosures related to ownership structure. While it is a specific regulatory disclosure, it is not a standard US SEC filing like 10-K or a general dividend announcement. Given the options, it is a specific regulatory disclosure about share capital structure. The closest fit among the provided codes is 'SHA' (Share Issue/Capital Change) or potentially 'RNS' (Regulatory Filings) as a catch-all for specific non-US regulatory notices. Since it explicitly details the total number of shares and voting rights, which is a fundamental aspect of capital structure reporting, 'SHA' is a strong candidate, although 'RNS' is often used for miscellaneous regulatory notices. However, since it is a formal declaration about the capital structure itself, and not just a transaction, I will check if there is a better fit. None of the other codes (like DVA for voting results, or DIRS for insider trades) fit. Since this is a formal, periodic disclosure about the total capital and voting rights, it falls under general regulatory reporting. Given the specific nature of reporting total voting rights, which is often tied to capital structure changes or thresholds, and lacking a specific 'Voting Rights Disclosure' code, 'RNS' (Regulatory Filings - fallback) is the safest classification for a non-standard, specific regulatory notice, unless the intent is to capture all capital structure updates under SHA. Since it's a monthly update on the *total* capital structure, and not a specific transaction (like a buyback or new issue), 'RNS' is the most appropriate fallback for this specific French regulatory filing type that doesn't map perfectly to the US-centric list.
2022-01-04 French
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Capital/Financing Update Classification · 1% confidence The document is titled "BILAN SEMESTRIEL S2 2021 DU CONTRAT DE LIQUIDITÉ" (Semi-annual balance sheet S2 2021 of the Liquidity Contract) and reports on the status of a liquidity contract as of December 31, 2021, detailing shares held and transactions (purchases/sales) during the second half of 2021. This type of report, detailing the status of a specific financial arrangement (liquidity contract/market making) over an interim period (semi-annual), aligns best with the definition of an Interim / Quarterly Report (IR), as it provides comprehensive financial/activity data for a period shorter than a year. It is not a full Annual Report (10-K), a general Earnings Release (ER), or a simple announcement of a report (RPA).
2022-01-03 French
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
M&A Activity Classification · 1% confidence The document is a press release dated December 20, 2021, announcing a specific transaction: Icade Santé acquiring the walls of three new nursing homes from ORPEA in Germany for approximately €57M. This announcement details a significant investment and acquisition activity related to real estate assets (Foncière santé). This type of announcement, focusing on a specific corporate transaction (M&A/Acquisition of assets), fits best under the 'Capital/Financing Update' (CAP) if it were about fundraising, or 'M&A Activity' (TAR) if it were a takeover bid. However, this is a specific real estate acquisition by a specialized property company (Icade Santé) from another company (ORPEA). Since it is not a formal regulatory filing like a 10-K or an earnings release, and it describes a major investment/acquisition, it aligns most closely with 'M&A Activity' (TAR) as it involves the transfer of significant assets between two entities, even if it's not a full merger or takeover bid. Given the options, TAR (Merger/Takeover Activity) is the closest fit for a major asset acquisition announcement, although 'CAP' (Capital/Financing Update) could also be argued due to the investment nature. I will select TAR as it describes a transaction between two companies involving asset transfer.
2021-12-20 French
Inside Information / Operations of the issuer (acquisitions, sales...)
Regulatory Filings Classification · 1% confidence The document is a press release dated December 20, 2021, announcing that Icade Santé has signed preliminary agreements to acquire three nursing home properties in Germany from ORPEA for approximately €57m. This announcement details a significant corporate transaction involving real estate acquisition and partnership strategy advancement. This type of announcement, detailing a major corporate action like an acquisition or significant investment, falls under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS) if it were a mandatory disclosure without a more specific category. Since it details a significant investment and expansion activity, 'CAP' is a strong candidate. However, given the nature of the transaction (acquisition of assets/real estate), and the fact that it is a press release announcing a deal rather than a formal regulatory filing like a 10-K or a specific financing document, it is best classified as a general corporate announcement related to capital deployment/investment strategy. In the provided definitions, 'CAP' (Capital/Financing Update) covers fundraising, financing activities, or capital structure changes. While this is an acquisition, it is a major capital deployment. If the acquisition was related to a takeover bid, it would be TAR. Since it is a strategic investment/acquisition announcement, and not a formal report, 'CAP' fits well as it relates to capital deployment. Alternatively, if it were a general announcement not fitting other specific categories, RNS would be used. Given the focus on investment and expansion, CAP is the most specific fit among the options that aren't formal reports.
2021-12-20 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled 'INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL' (Monthly information relating to the total number of voting rights and shares comprising the share capital) and is dated for November 30, 2021. It explicitly references French commercial code (Code de Commerce) and AMF regulations (Autorité des Marchés Financiers). It details the number of outstanding shares and total gross voting rights. This type of periodic disclosure regarding the total number of shares and voting rights is a specific regulatory filing requirement, often related to capital structure changes or mandatory periodic updates. While it touches upon capital structure, it is primarily a mandatory disclosure of voting rights/share count. This fits best under 'Regulatory Filings' (RNS) as a general regulatory disclosure, although it is highly specific. Given the options, it is a mandatory regulatory disclosure that doesn't fit perfectly into CAP (Capital/Financing Update) which usually implies fundraising or structural changes, or SHA (Share Issue/Capital Change) which implies an action taken. Since it is a mandatory periodic report on the capital base and voting rights under AMF rules, RNS is the most appropriate general regulatory category if a more specific one like SHA or CAP is not clearly indicated by the content (which focuses on reporting the current count, not announcing a change event). However, since it is a direct report on the capital structure components (shares and voting rights), it is closely related to 'Share Issue/Capital Change' (SHA) or a specific regulatory filing. Given the focus on the total number of shares and voting rights, which is a fundamental aspect of capital structure reporting, SHA might be considered, but RNS is safer for mandatory periodic regulatory updates not tied to a specific transaction announcement. Let's re-evaluate the definitions. None perfectly match 'Monthly Voting Rights Disclosure'. It is a regulatory filing. I will classify it as RNS (Regulatory Filings) as the fallback for specific regulatory disclosures not covered elsewhere, although it is very close to SHA.
2021-12-08 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.